Glyxambi
Manufacturing · 1-10 Employees
View Company Info for Free
Overview
Website
www.glyxambi.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Glyxambi
The empagliflozin and linagliptin combination once-daily pill, GLYXAMBI, helps lower a1c and blood sugar in adults with type 2 diabetes. Not for type 1 diabetes or diabetic ketoacidosis. Not studied in patients with history of pancreatitis.Explore more
Popular SearchesGlyxambiBoehringer Ingelheim Pharmaceuticals IncSIC Code 28,283NAICS Code 32,325Show more
Glyxambi Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Glyxambi your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Glyxambi
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Glyxambi has new funding data
Check out if Glyxambi is spiking on competitors!
Check if Glyxambi has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Glyxambi recently announced quarterly report
Click to see if Glyxambi had a recent Job posting/layoffs
Product Launch: Get notified when Glyxambi launches new products
Glyxambi, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Glyxambi
Compare insights from companies similar to Glyxambi, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Company Profile Activity
Activity Insights
Glyxambi is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Glyxambi is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Glyxambi.
Glyxambi Tech Stack
A closer look at the technologies used by Glyxambi
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Glyxambi
Sign Up For FreeTo access detailed company insights
The empagliflozin and linagliptin combination once-daily pill, GLYXAMBI, helps lower a1c and blood sugar in adults with type 2 diabetes. Not for type 1 diabetes or diabetic ketoacidosis. Not studied in patients with history of pancreatitis.... Read More
